Miragen Therapeutics Inc Asset Turnover Ratio (MGEN), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Miragen Therapeutics Inc   (NASDAQ: MGEN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Miragen Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Miragen Therapeutics Inc asset turnover ratio, the ability of Miragen Therapeutics Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.04 in the third quarter (Sep 30 2026), MGEN's balance sheet remain strong.

Within sector Miragen Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MGEN Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Jun 30 2025)
II. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Asset Change 2968.15 % 3525.78 % 1400.33 % -32.69 % -39.06 %
Y / Y Revenue Change 15228.57 % -67.73 % -89.21 % - -54.84 %
Asset Turnover Ratio (TTM) 0.04 0 0.01 - 0.11
MGEN's Total Ranking # # # # #
Seq. Asset Change -6.37 % 88.42 % 1673.59 % -1.95 % 10.65 %
Seq. Revenue Change 8967.61 % 278.67 % - - -80.91 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




MGEN Company Profile • Back to MGEN Efficiency Comparisons • Compare MGEN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Stoke Therapeutics Inc   0.07 $ 28.211  Millions$ 415.592  Millions
Intellia Therapeutics Inc   0.06 $ 52.887  Millions$ 840.157  Millions
Stablecoin Development Corporation  0.06 $ 7.246  Millions$ 126.127  Millions
Atrium Therapeutics Inc   0.06 $ 38.820  Millions$ 698.727  Millions
Seer Inc   0.05 $ 14.248  Millions$ 266.663  Millions
Nakamoto Inc   0.05 $ 30.503  Millions$ 572.769  Millions
Recursion Pharmaceuticals Inc   0.05 $ 68.232  Millions$ 1,312.008  Millions
Pluri Inc   0.05 $ 1.459  Millions$ 28.637  Millions
Abcellera Biologics Inc   0.05 $ 67.858  Millions$ 1,367.875  Millions
Lenz Therapeutics Inc   0.05 $ 12.359  Millions$ 256.189  Millions
Co diagnostics Inc   0.05 $ 0.859  Millions$ 18.906  Millions
Cytomx Therapeutics Inc   0.04 $ 14.027  Millions$ 314.207  Millions
Solana Company  0.04 $ 12.906  Millions$ 318.301  Millions
Vivos Inc  0.04 $ 0.092  Millions$ 2.349  Millions
Metagenomi Therapeutics Inc   0.04 $ 7.086  Millions$ 187.286  Millions
Aclaris Therapeutics Inc   0.03 $ 6.401  Millions$ 188.758  Millions
Ideaya Biosciences Inc   0.03 $ 36.535  Millions$ 1,166.348  Millions
Prime Medicine Inc   0.03 $ 7.061  Millions$ 275.090  Millions
Medicinova Inc   0.02 $ 0.936  Millions$ 43.496  Millions
Vivosim Labs Inc   0.02 $ 0.135  Millions$ 7.029  Millions
Dbv Technologies S a   0.02 $ 3.844  Millions$ 234.675  Millions
Alumis inc   0.01 $ 7.239  Millions$ 533.214  Millions
Cardiff Oncology Inc   0.01 $ 0.559  Millions$ 46.200  Millions
Anteris Technologies Global Corp   0.01 $ 2.332  Millions$ 227.598  Millions
Crispr Therapeutics Ag  0.01 $ 25.172  Millions$ 2,549.561  Millions
Eyepoint Inc   0.01 $ 2.578  Millions$ 261.635  Millions
Upstream Bio Inc   0.01 $ 2.870  Millions$ 299.747  Millions
Absci Corp  0.01 $ 1.487  Millions$ 230.095  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.